General Information
Application | Inhibitor |
---|
Description | Everolimus is a targeted, highly specific agent with an IC50 for binding to isolated FKBP-12, or FKBP-12 complexed to mTOR of 5 to 6 nM, and no significant activity against other protein kinases. |
---|
Cas NO. |
159351-69-6 |
---|
Purity | ≥98% |
---|---|
Molecular Weight | 958.22 |
Formula | C53H83NO14 |
Solubility |
DMSO: ≥ 54 mg/mL Everolimus is dissolved in 30% (w/v) Captisol |
---|
Target / IC50 | mTOR : 5-6 nM |
---|
Storage |
Powder : -20°C for 3 years Solvent : The compound is unstable in solutions, freshly prepared is recommended. |
---|
|
1 mg |
5 mg |
10 mg |
|
1 mM |
1.0436 mL | 5.2180 mL | 10.4360 mL | |
5 mM | 0.2087 mL | 1.0436 mL | 2.0872 mL | |
10 mM | 0.1044 mL | 0.5218 mL | 1.0436 mL |